Learn More
Invitrogen™ CRACC Polyclonal Antibody

Description
In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant human CRACC is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
Specifications
Specifications
| Antigen | CRACC |
| Applications | Flow Cytometry, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | SLAMF7 |
| Gene Accession No. | Q8BHK6 |
| Gene Alias | 19A; 19A24; 19A24 protein; 4930560D03Rik; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; CD319; CRACC; CS1; Leukocyte cell-surface antigen; membrane protein FOAP-12; Novel Ly9; novel LY9 (lymphocyte antigen 9) like protein; protein 19A; RGD1560190; SLAM family member 7; SLAMF7; UNQ576/PRO1138 |
| Gene Symbols | SLAMF7 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.